CorMedix Inc. (CRMD) stock
CRMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 13/30
$4.67−0.15 (-3.11%)
Close on Nov 17, 2026Market cap $364.00MP/E –Yield –
CorMedix total assets
Total assets on the balance sheet at the end of each period.
CorMedix's total assets was $904.05M at Jun 30, 2026. For fiscal 2025 it was $826.14M, up 595.1% from the year before. Over ten years it grew 36.4% a year on average. The highest annual figure on record is $826.14M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $826.14M | +595.1% |
| FY2024 | Dec 31, 2024 | $118.85M | +44.8% |
| FY2023 | Dec 31, 2023 | $82.06M | +32.3% |
| FY2022 | Dec 31, 2022 | $62.04M | -10.0% |
| FY2021 | Dec 31, 2021 | $68.95M | +39.8% |
| FY2020 | Dec 31, 2020 | $49.31M | +67.3% |
| FY2019 | Dec 31, 2019 | $29.48M | +56.6% |
| FY2018 | Dec 31, 2018 | $18.83M | +39.9% |
| FY2017 | Dec 31, 2017 | $13.45M | -38.6% |
| FY2016 | Dec 31, 2016 | $21.91M | -41.0% |
| FY2015 | Dec 31, 2015 | $37.10M | +627.8% |
| FY2014 | Dec 31, 2014 | $5.10M | +71.8% |
| FY2013 | Dec 31, 2013 | $2.97M | +157.3% |
| FY2012 | Dec 31, 2012 | $1.15M | -54.9% |
| FY2011 | Dec 31, 2011 | $2.56M | -71.1% |
| FY2010 | Dec 31, 2010 | $8.85M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $904.05M | +257.9% |
| Q1 FY2026 | Mar 31, 2026 | $815.64M | +445.3% |
| Q4 FY2025 | Dec 31, 2025 | $826.14M | +595.1% |
| Q3 FY2025 | Sep 30, 2025 | $750.86M | +867.8% |
| Q2 FY2025 | Jun 30, 2025 | $252.60M | +337.5% |
| Q1 FY2025 | Mar 31, 2025 | $149.58M | +119.9% |
| Q4 FY2024 | Dec 31, 2024 | $118.85M | +44.8% |
| Q3 FY2024 | Sep 30, 2024 | $77.59M | -15.1% |
| Q2 FY2024 | Jun 30, 2024 | $57.73M | +1.2% |
| Q1 FY2024 | Mar 31, 2024 | $68.02M | +14.8% |
| Q4 FY2023 | Dec 31, 2023 | $82.06M | +32.3% |
| Q3 FY2023 | Sep 30, 2023 | $91.43M | +47.3% |
| Q2 FY2023 | Jun 30, 2023 | $57.03M | -15.8% |
| Q1 FY2023 | Mar 31, 2023 | $59.23M | -8.8% |
| Q4 FY2022 | Dec 31, 2022 | $62.04M | -10.0% |
| Q3 FY2022 | Sep 30, 2022 | $62.08M | -17.7% |
| Q2 FY2022 | Jun 30, 2022 | $67.75M | -16.2% |
| Q1 FY2022 | Mar 31, 2022 | $64.93M | -22.9% |
| Q4 FY2021 | Dec 31, 2021 | $68.95M | +39.8% |
| Q3 FY2021 | Sep 30, 2021 | $75.39M | +88.4% |
| Q2 FY2021 | Jun 30, 2021 | $80.86M | +233.6% |
| Q1 FY2021 | Mar 31, 2021 | $84.26M | +207.5% |
| Q4 FY2020 | Dec 31, 2020 | $49.31M | +67.3% |
| Q3 FY2020 | Sep 30, 2020 | $40.02M | +18.7% |
| Q2 FY2020 | Jun 30, 2020 | $24.24M | -12.1% |
| Q1 FY2020 | Mar 31, 2020 | $27.40M | +0.3% |
| Q4 FY2019 | Dec 31, 2019 | $29.48M | +56.6% |
| Q3 FY2019 | Sep 30, 2019 | $33.72M | +318.9% |
| Q2 FY2019 | Jun 30, 2019 | $27.56M | +365.0% |
| Q1 FY2019 | Mar 31, 2019 | $27.31M | +184.2% |
| Q4 FY2018 | Dec 31, 2018 | $18.83M | +39.9% |
| Q3 FY2018 | Sep 30, 2018 | $8.05M | -42.2% |
| Q2 FY2018 | Jun 30, 2018 | $5.93M | -72.0% |
| Q1 FY2018 | Mar 31, 2018 | $9.61M | -35.7% |
| Q4 FY2017 | Dec 31, 2017 | $13.45M | -38.6% |
| Q3 FY2017 | Sep 30, 2017 | $13.93M | -51.7% |
| Q2 FY2017 | Jun 30, 2017 | $21.16M | – |
| Q1 FY2017 | Mar 31, 2017 | $14.93M | – |
| Q4 FY2016 | Dec 31, 2016 | $21.91M | – |
| Q3 FY2016 | Sep 30, 2016 | $28.84M | – |
See a number that looks wrong?